| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/06/2011 | US20110003885 Methods and compositions for inhibition of immune responses and autoimmunity |
| 01/06/2011 | US20110003884 Viral Vectors and Methods of Use |
| 01/06/2011 | US20110003882 RNAi Modulation of AHA and Therapeutic Uses Thereof |
| 01/06/2011 | US20110003881 Single stranded extended dicer substrate agents and methods for the specific inhibition of gene expression |
| 01/06/2011 | US20110003880 Compositions and methods for inhibiting optic nerve damage |
| 01/06/2011 | US20110003879 Antisense oligonucleotides targeted to the coding region of thymidylate synthase and uses thereof |
| 01/06/2011 | US20110003878 Novel derivatives of phthalimide as histone deacetylase inhibitors |
| 01/06/2011 | US20110003877 SMAC Mimetic |
| 01/06/2011 | US20110003876 Tetrahydroindoles Having Sphingosine-1-Phosphate Receptor Activity |
| 01/06/2011 | US20110003874 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 01/06/2011 | US20110003873 Pharmaceutical composition and its use in the preparation of a medicament for the treatment of cerebrovascular diseases |
| 01/06/2011 | US20110003872 Material formed from dendritic molecules containing associative groups |
| 01/06/2011 | US20110003870 Method of treatment of a neurological disorder |
| 01/06/2011 | US20110003869 Use of Succinate Dehydrogenase Inhibitors for Controlling Sclerotinia ssp. |
| 01/06/2011 | US20110003868 Treatment of a neuropathy with rapid release aminopyridine |
| 01/06/2011 | US20110003867 Novel 2-ethyl-methyl-amino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators |
| 01/06/2011 | US20110003866 Novel 2-dimethylamino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators |
| 01/06/2011 | US20110003865 Novel 2-diethylamino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators |
| 01/06/2011 | US20110003864 Crystalline 1-(3-fluorophenyl)-5-methyl-2-(1h)pyridone, the preparation methods, compositions and applications thereof |
| 01/06/2011 | US20110003863 Method for synthesizing pirfenidone |
| 01/06/2011 | US20110003862 3-Animopyraolines for Treatment of Neurodegenerative and Psychiatric Diseases |
| 01/06/2011 | US20110003861 2-aryl and 2-heteroaryl 4h-1-benzopyran-4-one-6-amidino derivatives, new pharmacological agents for the treatment of arthritis, cancer and related pain |
| 01/06/2011 | US20110003860 Hydroxyl compounds and compositions for cholesterol management and related uses |
| 01/06/2011 | US20110003859 N- (6-aminopyridin-3-yl) -3- (sulfonamido) benzamide derivatives as b-raf inhibitors for the treatment of cancer |
| 01/06/2011 | US20110003858 Multimeric heterocyclic compounds useful as neutrophil elastase inhibitors |
| 01/06/2011 | US20110003857 Stabilized, antimicrobially effective composition with a content of bispyridinium alkane |
| 01/06/2011 | US20110003856 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| 01/06/2011 | US20110003855 Antiviral compounds for the treatment of hcv infection |
| 01/06/2011 | US20110003854 Breast cancer treatment and treatment prediction |
| 01/06/2011 | US20110003853 Metalloproteinase Inhibitors |
| 01/06/2011 | US20110003852 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| 01/06/2011 | US20110003851 Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors |
| 01/06/2011 | US20110003850 Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators |
| 01/06/2011 | US20110003849 Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment |
| 01/06/2011 | US20110003848 Polymorphic Form Of A [1,2,4]Triazole[4,3-A] Pyridine Derivative For Treating Inflammatory Diseases |
| 01/06/2011 | US20110003847 Prasugrel Salts with Improved Properties |
| 01/06/2011 | US20110003846 Polymorph and amorphous form of (s)-(+)-clopidogrel bisulfate |
| 01/06/2011 | US20110003845 Substituted azabicyclic compounds and the use thereof |
| 01/06/2011 | US20110003844 Regulation of cardiac contractility and heart failure propensity |
| 01/06/2011 | US20110003843 Novel compounds derived from indole and pharmaceutical compositions containing them |
| 01/06/2011 | US20110003842 Marker for determination of sensitivity to anti-cancer agent |
| 01/06/2011 | US20110003841 Bioactive composition for the treatment of the hiv/aids, method for manufacturing and using the same |
| 01/06/2011 | US20110003840 Pyridoindolobenzox-and thiazepine derivatives and uses thereof |
| 01/06/2011 | US20110003839 Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases |
| 01/06/2011 | US20110003837 Modified release formulations of hmg coa reductase inhibitors |
| 01/06/2011 | US20110003836 Pro-Neurogenic Compounds |
| 01/06/2011 | US20110003835 Methods for the treatment of respiratory depression |
| 01/06/2011 | US20110003834 Production method and production apparatus for a high theobromine-containing composition |
| 01/06/2011 | US20110003833 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 01/06/2011 | US20110003832 NEW CAPPED Pyrazinoylguanidine SODIUM CHANNEL BLOCKERS |
| 01/06/2011 | US20110003831 N-(-3-methoxy-5-methylpyrazin-2-yl)-2-(4-'1,3,4-oxadiazol-2-yl!phenyl)pyridine-3 sulphonamide as an anticancer agent |
| 01/06/2011 | US20110003830 Process for the preparation of 3-amino-8-(1-piperazinyl)-2h-1-benzopyran-2-one and salts and solvates thereof |
| 01/06/2011 | US20110003829 Enrofloxacin hexahydrate |
| 01/06/2011 | US20110003828 Prodrugs of nh-acidic compounds |
| 01/06/2011 | US20110003827 HIV protease inhibiting compounds |
| 01/06/2011 | US20110003826 Anticoagulant compounds, pharmaceutical compositions on their basis to treat thrombotic conditions, and plasma-substituting solution to correct hypercoagulation defects of hemodilution |
| 01/06/2011 | US20110003825 Substituted amide beta secretase inhibitors |
| 01/06/2011 | US20110003824 Caspase Inhibitors and Uses Thereof |
| 01/06/2011 | US20110003823 Compositions and methods for treatment of diseases and conditions associated with vasodilation and/or vascular leakage |
| 01/06/2011 | US20110003822 P2x3 receptor antagonists for treatment of pain |
| 01/06/2011 | US20110003821 Pyrrolotriazine kinase inhibitors |
| 01/06/2011 | US20110003820 Pyrazolopyrimidines, a process for their preparation and their use as medicine |
| 01/06/2011 | US20110003819 Methods of treating multiple sclerosis using neurotrophin mimetics |
| 01/06/2011 | US20110003818 Substituted 2-Carboxamide Cycloamino Ureas |
| 01/06/2011 | US20110003816 Ophthalmic composition |
| 01/06/2011 | US20110003815 Diphenyl substituted cycloalkanes |
| 01/06/2011 | US20110003814 Pyrimidines useful as modulators of voltage-gated ion channels |
| 01/06/2011 | US20110003813 Substituted biaryl piperazinyl-pyridine analogues |
| 01/06/2011 | US20110003812 Human Adam-10 Inhibitors |
| 01/06/2011 | US20110003811 Subsituted pyridine derivatives |
| 01/06/2011 | US20110003810 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors |
| 01/06/2011 | US20110003809 Imidazo [4,5-b] pyridine derivatives used as raf inhibitors |
| 01/06/2011 | US20110003808 Octahydroquinolizines for antidiabetic treatment |
| 01/06/2011 | US20110003807 Thiazole derivatives |
| 01/06/2011 | US20110003806 Heteroaryls and uses thereof |
| 01/06/2011 | US20110003805 Concomitant drug |
| 01/06/2011 | US20110003804 Oxazolidinones For the Treatment and/or Prophylaxis of Heart Failure |
| 01/06/2011 | US20110003803 Compositions and methods for treating ophthalmic, otic, or nasal infections |
| 01/06/2011 | US20110003802 Bridged N-Cyclic Sulfonamido Inhibitors of Gamma Secretase |
| 01/06/2011 | US20110003801 Benzimidazole derivatives useful as trpm8 channel modulators |
| 01/06/2011 | US20110003800 Benzimidazole derivatives useful as trpm8 channel modulators |
| 01/06/2011 | US20110003799 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators |
| 01/06/2011 | US20110003798 Compounds and compositions as kinase inhibitors |
| 01/06/2011 | US20110003797 HEXAHYDROCYCLOPENTYL[f]INDAZOLE CARBOXAMIDES AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS |
| 01/06/2011 | US20110003796 Method for the treatment of psychic disorders |
| 01/06/2011 | US20110003795 Substituted Aromatic Carboxamide and Urea Derivatives as Vanilloid Receptor Ligands |
| 01/06/2011 | US20110003794 Naphthyridine Integrase Inhibitors |
| 01/06/2011 | US20110003793 AZINONE-SUBSTITUTED AZEPINO[b]INDOLE AND PYRIDO-PYRROLO-AZEPINE MCH-1 ANTAGONISTS, METHODS OF MAKING, AND USE THEREOF |
| 01/06/2011 | US20110003792 Anti-inflammatory agents |
| 01/06/2011 | US20110003791 Cyclized Derivatives as EG-5 Inhibitors |
| 01/06/2011 | US20110003790 Pyrido [4, 3-d] pyrimidinone derivatives as kinase inhibitors |
| 01/06/2011 | US20110003789 5-aminocyclylmethyl-oxazolidin-2-one derivatives |
| 01/06/2011 | US20110003788 Fused heterocyclic derivative and use thereof |
| 01/06/2011 | US20110003787 Novel phenylpyrrole derivative |
| 01/06/2011 | US20110003786 2-Carboxamide Cycloamino Ureas |
| 01/06/2011 | US20110003785 Fused Thiazole Derivatives As Kinase Inhibitors |
| 01/06/2011 | US20110003784 Opsin-binding ligands, compositions and methods of use |
| 01/06/2011 | US20110003783 Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
| 01/06/2011 | US20110003782 23-Substituted Bile Acids as TGR5 Modulators and Methods of Use Thereof |
| 01/06/2011 | US20110003781 Non-Sedating Antihistamine Injection Formulations and Methods of Use Thereof |